Home
Clinical Resources Search
PQI: Ruxolitinib (Jakafi®): Managing Myelofibrosis Patients

Ruxolitinib (Jakafi®): Managing Myelofibrosis Patients

Download PQI pdf 0.13MB

Last Updated: April 29, 2024

By: Todd Murphree, PharmD

About this PQI

Ruxolitinib is a selective JAK2 inhibitor used for the treatment of myelofibrosis (MF). This PQI will review the close monitoring of platelets required to ensure appropriate dose and avoid severe thrombocytopenia due to the therapy.

More About This PQI

PQI:

Ruxolitinib-Jakafi-Managing-Treatment-of-Polycythemia-Vera_PQI_NCODA pdf 0.12MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Hematological Malignancies Myelofibrosis (MF) Myeloproliferative Neoplasm Jakafi Ruxolitinib

PQI

PQI: Ibrutinib Dosing Optimization

Author: Nick Bouchard, PharmD | Danielle Maciorowski, PharmD

Frequently Searched

Supported by

Ruxolitinib (Jakafi®): Managing Myelofibrosis Patients

About this PQI

More About This PQI

PQI:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Vorasidenib (Voranigo®)

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI Podcast S7 Ep 8: Sickle Cell Disease Insights

The PQI Podcast S3 Ep 15: Myeloproliferative Neoplasms

PQI: Proactive Symptom Management in Myelofibrosis

PQI: Pacritinib (Vonjo®) in Cytopenic Myelofibrosis

Treatment Support Kit: Pacritinib

PQI in Action: Ropeginterferon alfa-2b-njft (BESREMi®) Use in Polycythemia Vera

PQI: Ruxolitinib (Jakafi®): Managing Treatment of Polycythemia Vera

PQI in Action: Extolling the Benefits of Identifying Polycythemia Vera Patients and Myelofibrosis within Medically Integrated Dispensing Practices